Overexpression of LOXIN Protects Endothelial Progenitor Cells From Apoptosis Induced by Oxidized Low Density Lipoprotein
Authors:
- Carlos VeasCVCarlos Veas
- Casandra JaraCJCasandra Jara
- Naomi D. WillisNWNaomi D. Willis
- Karen Pérez-ContrerasKPKaren Pérez-Contreras
- Nicolas GutierrezNGNicolas Gutierrez
- Jorge ToledoJTJorge Toledo
- Paulina FernandezPFPaulina Fernandez
- Claudia RadojkovicCRClaudia Radojkovic
- Felipe A. ZuñigaFelipe A. Zuñiga
- Carlos EscuderoCarlos Escudero
- Claudio AguayoCAClaudio Aguayo
- 1 April 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 67 (4) , 326-335
Abstract
Human endothelial progenitor cells (hEPC) are adult stem cells located in the bone marrow and peripheral blood. Studies have indicated that hEPC play an important role in the recovery and repair of injured endothelium, however, their quantity and functional capacity is reduced in several diseases including hypercholesterolemia. Recently, it has been demonstrated that hEPC express lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and its activation by oxidized low-density lipoprotein (ox-LDL) induces cellular dysfunction and apoptosis. This study aimed to investigate whether overexpression of LOXIN, a truncated isoform of LOX-1 that acts as a dominant negative, plays a protective role against ox-LDL-induced apoptosis in hEPC. Human endothelial progenitor cells exposed to ox-LDL showed a significant increase in LOX-1 expression, and apoptosis began at ox-LDL concentrations above 50 μg/mL. All hEPC apoptosed at 200 μg/mL ox-LDL. High LOXIN expression was generated using adenoviral systems in hEPC and SiHa cells transduced with 100 colony-forming units per cell. Transduced LOXIN localized to the plasma membrane and blocked ox-LDL uptake mediated by LOX-1. Overexpression of LOXIN protected hEPC from ox-LDL-induced apoptosis, and therefore maybe a novel way of improving hEPC function and quantity. These results suggest that adenoviral vectors of LOXIN may provide a possible treatment for diseases related to ox-LDL and vascular endothelium dysfunction, including atherosclerosis.Keywords
This publication has 64 references indexed in Scilit:
- LOX-1, OxLDL, and AtherosclerosisMediators of Inflammation, 2013
- Overexpression of scavenger receptor LOX-1 in endothelial cells promotes atherogenesis in the ApoE−/− mouse modelCardiovascular Pathology, 2011
- Mononuclear cell therapy attenuates atherosclerosis in apoE KO miceLipids in Health and Disease, 2011
- Hyperglycemia and Oxidized-LDL exert a deleterious effect on Endothelial Progenitor Cell migration in Type 2 Diabetes MellitusThrombosis Research, 2010
- Oxidized Low-Density Lipoprotein Induces Apoptosis in Endothelial Progenitor Cells by Inactivating the Phosphoinositide 3-Kinase/Akt PathwayJournal of Vascular Research, 2010
- Plasma Oxidized Low-Density Lipoprotein Levels and Arterial Stiffness in Older AdultsHypertension, 2009
- Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1Journal of Lipid Research, 2008
- Biologic Properties of Endothelial Progenitor Cells and Their Potential for Cell TherapyProgress in Cardiovascular Diseases, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Origins of circulating endothelial cells and endothelial outgrowth from bloodJournal of Clinical Investigation, 2000